Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

26.73
+0.49001.87%
Post-market: 26.67-0.0600-0.22%19:59 EST
Volume:54.34M
Turnover:1.45B
Market Cap:151.49B
PE:18.93
High:26.89
Open:26.40
Low:26.18
Close:26.24
Loading ...

BRIEF-Pfizer And Astellas’ Padcev Plus Keytruda Shows Long-Term Efficacy In First-Line Treatment Of Locally Advanced Or Metastatic Urothelial Cancer

Reuters
·
11 Feb

Astellas Pharma Inc: Enfortumab Vedotin Plus Pembrolizumab Continues to Demonstrate Superior Efficacy Versus Chemotherapy in Broad Population

THOMSON REUTERS
·
11 Feb

Astellas Pharma Inc: No New Safety Signals Identified From Phase 3 EV-302 Trial

THOMSON REUTERS
·
11 Feb

Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)

Business Wire
·
11 Feb

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024

Business Wire
·
11 Feb

Should Pfizer Stock Be in Your Portfolio Post a Robust Q4 Performance?

Zacks
·
10 Feb

Pfizer Price Target Maintained With a $33.00/Share by Guggenheim

Dow Jones
·
10 Feb

Tech Pro Living On 50% Income For 20 Years With $5,200/Month In Dividend Shares His 7 Picks – 'How I Built A $1M Portfolio Without Big Wins'

Benzinga
·
10 Feb

Royalty Pharma Earnings: What To Look For From RPRX

StockStory
·
10 Feb

Better High-Yield Dividend Stock: Pfizer vs. Merck

Motley Fool
·
10 Feb

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Motley Fool
·
10 Feb

Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 68% of the company

Simply Wall St.
·
09 Feb

Is Now a Good Time to Buy the Dip on Pfizer?

Motley Fool
·
09 Feb

3 Dividend Stocks to Double Up on Right Now

Motley Fool
·
09 Feb

Why Pfizer (PFE) Is Declining?

Insider Monkey
·
09 Feb

Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
08 Feb